These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23809433)

  • 1. CA-S27: a novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma.
    Silsirivanit A; Araki N; Wongkham C; Vaeteewoottacharn K; Pairojkul C; Kuwahara K; Narimatsu Y; Sawaki H; Narimatsu H; Okada S; Sakaguchi N; Wongkham S
    Cancer Sci; 2013 Oct; 104(10):1278-84. PubMed ID: 23809433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.
    Silsirivanit A; Matsuda A; Kuno A; Tsuruno C; Uenoyama Y; Seubwai W; Angata K; Teeravirote K; Wongkham C; Araki N; Takahama Y; Wongkham S; Narimatsu H
    Clin Chim Acta; 2020 Nov; 510():142-149. PubMed ID: 32659223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma.
    Silsirivanit A; Araki N; Wongkham C; Pairojkul C; Narimatsu Y; Kuwahara K; Narimatsu H; Wongkham S; Sakaguchi N
    Cancer; 2011 Aug; 117(15):3393-403. PubMed ID: 21287531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of tumor markers for cholangiocarcinoma and evaluation of their diagnostic potential.
    Sirisinha S; Prempracha N; Tengchaisri T; Hongsrijinda N; Chawengkirttikul R; Chinchai T
    Asian Pac J Allergy Immunol; 1994 Jun; 12(1):73-81. PubMed ID: 7872996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma.
    Bamrungphon W; Prempracha N; Bunchu N; Rangdaeng S; Sandhu T; Srisukho S; Boonla C; Wongkham S
    Cancer Lett; 2007 Mar; 247(2):301-8. PubMed ID: 16793202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
    J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach.
    Pattanapairoj S; Silsirivanit A; Muisuk K; Seubwai W; Cha'on U; Vaeteewoottacharn K; Sawanyawisuth K; Chetchotsak D; Wongkham S
    Clin Biochem; 2015 Jul; 48(10-11):668-73. PubMed ID: 25863112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma.
    Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L
    J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of bile and serum mucin5AC in cholangiocarcinoma: diagnostic performance and biologic significance.
    Danese E; Ruzzenente O; Ruzzenente A; Iacono C; Bertuzzo F; Gelati M; Conci S; Bendinelli S; Bonizzato G; Guglielmi A; Salvagno GL; Lippi G; Guidi GC
    Surgery; 2014 Nov; 156(5):1218-24. PubMed ID: 25151557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic performance of serum MUC5AC for cholangiocarcinoma: A systematic review and meta-analysis.
    Xuan J; Li J; Zhou Z; Zhou R; Xu H; Wen W
    Medicine (Baltimore); 2016 Jun; 95(24):e3513. PubMed ID: 27310944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma.
    Wongkham S; Sheehan JK; Boonla C; Patrakitkomjorn S; Howard M; Kirkham S; Sripa B; Wongkham C; Bhudhisawasdi V
    Cancer Lett; 2003 May; 195(1):93-9. PubMed ID: 12767517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA; Ahmed NS
    Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
    Tang Z; Yang Y; Wang X; Meng W; Li X
    BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma.
    Boonla C; Wongkham S; Sheehan JK; Wongkham C; Bhudhisawasdi V; Tepsiri N; Pairojkul C
    Cancer; 2003 Oct; 98(7):1438-43. PubMed ID: 14508831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients.
    Chaiyarit P; Sithithaworn P; Thuwajit C; Yongvanit P
    Clin Oral Investig; 2011 Aug; 15(4):477-83. PubMed ID: 20446100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
    Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
    Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD15 expression in dysplastic and neoplastic tissue of the bile duct - a potential novel tool for differential diagnosis of indeterminate biliary stricture.
    Walter D; Herrmann E; Winkelmann R; Albert JG; Liese J; Schnitzbauer A; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S
    Histopathology; 2016 Dec; 69(6):962-970. PubMed ID: 27442966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile.
    Wang B; Chen L; Chang HT
    Biomark Med; 2016 Jun; 10(6):613-9. PubMed ID: 27232281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.